Last updated: November 21, 2023
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

3

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT06134388
  • Ages 18-65
  • Both

Study Design

Total Participants: 50
Study Start date:
September 01, 2023
Estimated Completion Date:
September 01, 2025